Withdrawal of Flovent Led to Discontinuation of Inhaled Steroids for Children With Asthma

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 2, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 2, 2025 -- For children using fluticasone propionate, the withdrawal of the brand-name drug (Flovent) was associated with increased discontinuation of inhaled steroid therapy, according to a research letter published online April 26 in the Journal of the American Medical Association to coincide with the annual meeting of the Pediatric Academic Societies, held from April 24 to 28 in Honolulu.

Kao-Ping Chua, M.D., Ph.D., from the University of Michigan Medical School in Ann Arbor, and colleagues conducted a difference-in-differences analysis to examine whether the withdrawal of brand-name fluticasone propionate was associated with discontinuation of inhaled steroid therapy. The analyses included children aged 0 to 18 years with one or more dispensed inhaled steroid prescriptions in quarter 4 of 2021, 2022, and/or 2023. The treatment group included children for whom the only inhaled steroid prescriptions dispensed to them during these index quarters were for brand-name fluticasone propionate (1,980,963 person-years of data from 1,411,184 children), while the control group included children for whom the only inhaled steroid prescriptions dispensed during the index quarters were for other inhaled steroids, including the authorized generic fluticasone propionate (1,237,802 person-years of data from 969,268 children).

The researchers found that the treatment group experienced a 6.0 percentage point greater increase in the probability of having no inhaled steroid dispensing compared with the control group. Between 2021 and 2022, this probability increased 1.4 percentage points more in the control group versus the treatment group. Difference-in-differences estimates were larger among children aged 0 to 5 years versus older children and among Medicaid-insured children versus commercially insured children.

"Findings suggest that elimination of the Medicaid rebate cap was potentially associated with unintended consequences," the authors write.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-03 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords